US Physical Therapy EVP Binstein Sells 2,000 Shares at $84.79/Share.

US Physical Therapy Inc /NV [USPH] has announced that EVP General Counsel & Secretary, Binstein Richard, has sold 2000 shares at a price of $84.79 per share on August 19, 2025.

US Physical Therapy Inc. /NV [USPH] has recently disclosed that EVP General Counsel & Secretary, Richard Binstein, sold 2,000 shares of the company's stock on August 19, 2025, at a price of $84.79 per share. The transaction, filed under SEC Form 4, represents a modest block of shares, reducing Binstein's direct holdings to 17,867 shares [1].

The filing highlights that most of Binstein's holdings (15,726 shares) are restricted and subject to a staggered vesting schedule through 2029, which limits near-term liquidity of those shares. The transaction itself appears routine and is documented via Form 4; no convertible or derivative transactions are reported. For investors tracking insider activity, the sale is a data point but the substantial restricted position indicates continued alignment with the company via time-based vesting [1].

Analysts have been optimistic about USPH, with the iShares U.S. Healthcare Providers ETF (Symbol: IHF) having an implied analyst target price of $109.67 per share, representing a 23.89% upside from the recent price of $88.52 [2]. This optimism is reflected in the company's valuation metrics, with a forward P/E ratio of 33.65 and a PEG ratio of 4.40, suggesting that analysts believe in the company's future growth prospects [3].

In summary, while the insider sale is a routine event, it provides investors with a snapshot of the company's insider activity. The substantial restricted position held by Binstein indicates a long-term commitment to the company, while the analyst targets suggest optimism about USPH's future performance.

References:
[1] https://www.stocktitan.net/sec-filings/USPH/form-4-us-physical-therapy-inc-insider-trading-activity-c6598ef96b17.html
[2] https://www.nasdaq.com/articles/analysts-see-16-gains-ahead-holdings-ihf
[3] https://www.nasdaq.com/articles/asth-or-usph-which-better-value-stock-right-now